Literature DB >> 20386928

Characterisation of renal immune cell infiltrates in children with nephrotic syndrome.

Kerstin Benz1, Maike Büttner, Katalin Dittrich, Valentina Campean, Jörg Dötsch, Kerstin Amann.   

Abstract

There is increasing evidence that not only T cells but also B cells may play an important role in the pathogenesis of idiopathic nephrotic syndrome (NS). We have evaluated the infiltrating immune cells found in renal biopsies from 38 children with NS using immunohistochemistry techniques involving antibodies against T cells (CD3, CD4, CD8, FoxP3), B cells (CD20), macrophages (CD68) and follicular dendritic cells (CD21). Kidney biopsies with thin basement membrane disease were used as controls. We found higher numbers of interstitial CD3-positive T cells and macrophages in patients with focal segmental glomerulosclerosis (FSGS) than in those with minimal change glomerulopathy (MCGN) and in the controls, and significantly lower FoxP3-positive cells in patients with FSGS, MCGN and steroid-dependent NS than in the controls. Significantly higher numbers of glomerular B cells were found in FSGN patients than in MCGN patients and controls. Of note, in three patients who were later successfully treated with anti-CD20 antibody rituximab, the number of renal B cells was negligible in the preceding biopsy. In conclusion, the higher numbers of interstitial CD3-positive T cells in renal biopsies of pediatric patients with FSGS argue for a higher inflammatory activity. The significantly higher number of glomerular B cells in FSGS patients may indicate a particular pathogenetic role or epiphenomenon in this disease. However, patients with no interstitial or glomerular B cells could also benefit from rituximab treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386928     DOI: 10.1007/s00467-010-1507-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.

Authors:  Rodney D Gilbert; Eleanor Hulse; Susan Rigden
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

2.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

Review 3.  Urinary macrophages as activity markers of renal injury.

Authors:  O Hotta; N Yusa; H Kitamura; Y Taguma
Journal:  Clin Chim Acta       Date:  2000-07       Impact factor: 3.786

4.  Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.

Authors:  Takehiko Wada; Jeffrey W Pippin; Caroline B Marshall; Sian V Griffin; Stuart J Shankland
Journal:  J Am Soc Nephrol       Date:  2005-06-29       Impact factor: 10.121

5.  B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.

Authors:  Cornelis Scheepstra; Fréderike J Bemelman; Chris van der Loos; Ajda T Rowshani; Karlijn A M I van Donselaar-Van der Pant; Mirza M Idu; Ineke J M ten Berge; Sandrine Florquin
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

6.  Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.

Authors:  Kerstin Benz; Jörg Dötsch; Wolfgang Rascher; Daniel Stachel
Journal:  Pediatr Nephrol       Date:  2004-04-08       Impact factor: 3.714

7.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

Authors:  Minnie Sarwal; Mei-Sze Chua; Neeraja Kambham; Szu-Chuan Hsieh; Thomas Satterwhite; Marilyn Masek; Oscar Salvatierra
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

8.  Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.

Authors:  M J Kemper; T Meyer-Jark; M Lilova; D E Müller-Wiefel
Journal:  Clin Nephrol       Date:  2003-10       Impact factor: 0.975

9.  Rituximab treatment of idiopathic membranous nephropathy.

Authors:  F C Fervenza; F G Cosio; S B Erickson; U Specks; A M Herzenberg; J J Dillon; N Leung; I M Cohen; D N Wochos; E Bergstralh; M Hladunewich; D C Cattran
Journal:  Kidney Int       Date:  2007-10-17       Impact factor: 10.612

Review 10.  Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.

Authors:  José G van den Berg; Jan J Weening
Journal:  Clin Sci (Lond)       Date:  2004-08       Impact factor: 6.124

View more
  21 in total

1.  Ofatumumab for the treatment of childhood nephrotic syndrome.

Authors:  Chia-Shi Wang; Rochelle Schmidt Liverman; Rouba Garro; Roshan Punnoose George; Anastacia Glumova; Alana Karp; Stephanie Jernigan; Barry Warshaw
Journal:  Pediatr Nephrol       Date:  2017-02-17       Impact factor: 3.714

Review 2.  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

3.  Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.

Authors:  JunYuan Bai; XiaoWei Pu; YunXia Zhang; Enlai Dai
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Cláudia Martins Carneiro; Dirceu de Sousa Melo; Karine Beatriz Costa; Fábio Lourenço Tadeu Guimarães; Etel Rocha-Vieira; Érica Leandro Marciano Vieira; Ana Cristina Simões e Silva
Journal:  Mediators Inflamm       Date:  2015-05-07       Impact factor: 4.711

5.  The novel diagnostic biomarkers for focal segmental glomerulosclerosis.

Authors:  Mohsen Nafar; Shiva Kalantari; Shiva Samavat; Mostafa Rezaei-Tavirani; Dorothea Rutishuser; Roman A Zubarev
Journal:  Int J Nephrol       Date:  2014-03-26

6.  Early B-cell factor 1 is an essential transcription factor for postnatal glomerular maturation.

Authors:  Jackie A Fretz; Tracy Nelson; Heino Velazquez; Yougen Xi; Gilbert W Moeckel; Mark C Horowitz
Journal:  Kidney Int       Date:  2013-10-30       Impact factor: 10.612

7.  Immunohistochemical Expression of FOXP3+ Regulatory T Cells in Proteinuric Primary Glomerulopathies.

Authors:  Georgios Vlachopanos; Argyrios Georgalis; Pinelopi Korkolopoulou; Efstratios Patsouris; Harikleia Gakiopoulou
Journal:  Int J Nephrol       Date:  2021-07-10

Review 8.  Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2.

Authors:  Peter Stenvinkel; Glenn M Chertow; Prasad Devarajan; Adeera Levin; Sharon P Andreoli; Sripal Bangalore; Bradley A Warady
Journal:  Kidney Int Rep       Date:  2021-05-04

9.  T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.

Authors:  Josephine M Forbes; Domenica A McCarthy; Andrew J Kassianos; Tracey Baskerville; Amelia K Fotheringham; Kurt T K Giuliani; Anca Grivei; Andrew J Murphy; Michelle C Flynn; Mitchell A Sullivan; Preeti Chandrashekar; Rani Whiddett; Kristen J Radford; Nicole Flemming; Sam S Beard; Neisha D'Silva; Janelle Nisbet; Adam Morton; Stephanie Teasdale; Anthony Russell; Nicole Isbel; Timothy Jones; Jennifer Couper; Helen Healy; Mark Harris; Kim Donaghue; David W Johnson; Andrew Cotterill; Helen L Barrett; Trisha O'Moore-Sullivan
Journal:  Diabetes       Date:  2021-03-18       Impact factor: 9.337

10.  Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice.

Authors:  Shun-Min Yang; Kuo-Feng Hua; Yu-Chuan Lin; Ann Chen; Jia-Ming Chang; Louis Kuoping Chao; Chen-Lung Ho; Shuk-Man Ka
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.